[Long-term results of treatment of Parkinson's disease with bromocriptine and domperidone (author's transl)].
Thirty-seven parkinsonian patients treated with bromocriptine +/- domperidone were examined eighteen months later. Fifteen continued the same treatment; 10 also received L-DOPA plus a peripheral DOPA-decarboxylase-inhibitor; the others resumed L-DOPA therapy. Thus, by limiting peripheral side effects, domperidone permits effective doses of bromocriptine.